After 28 days, oxidation reduces potency below clinically effective levels a stability study published in the International Journal of Pharmaceutics found potency dropped to 78% at day 35 and 61% by day 42
Educational Information Only All information provided on our website, including product descriptions, research summaries, scientific literature references, blog posts, and any other content, is provided strictly for educational and informational purposes only
Acta Pharmacol Sin 29(11):13191326
(4) Synergistic therapy: Combined treatment with isoliquiritigenin (ISL) enhances IRS1-PI3K-Akt signaling, mitigating the accumulation and infiltration of M1-ATMs and ATMs crosstalk with adipocytes while enhancing glucose uptake in DIO mice [181]
Primary Benefits: Stimulates lipolysis (the breakdown of fat)
The Cleveland Clinic notes that IV nutrient therapy may be appropriate in select clinical contexts when oral intake is limited or absorption is impaired